Clinical Trial Update: Pioglityazone and Imatinib for CML Patients [Phase 2]

View source ↗

Summary

Phase 2 trial examining pioglitazone in combination with imatinib for chronic myeloid leukemia has completed; no results are provided in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Actos (Pioglitazone)
• Gleevec (Imatinib)

Snippet

Sponsor: Versailles Hospital | Conditions: Leukemia, Myeloid, Chronic-Phase | Phase 2 | Status: COMPLETED